I'm in after reading the recent presentation and looking at the potential.
With a fully diluted market cap < $30m and two potential game changing technologies this is a no brainer IMO.
VibroVein sounds promising, but may take some time before getting to market so not really factoring that in at the moment.
BreatheAssist is looking at being on the market within 12 months and could easily become the market leading technology with it's many benefits. With a competitor doing $US75m in sales and us having a superior product with more market applications, this could have many bags in it.
BreatheAssist alone could potentially be worth $US500m+ within a few years... possibly more as new applications come on board.
Add to My Watchlist
What is My Watchlist?